Literature DB >> 15054041

Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy.

Vahid Asnafi1, Kheira Beldjord, Marta Libura, Patrick Villarese, Corrine Millien, Paola Ballerini, Emilienne Kuhlein, Marina Lafage-Pochitaloff, Eric Delabesse, Olivier Bernard, Elizabeth Macintyre.   

Abstract

Postnatal thymic involution occurs progressively throughout the first 3 decades of life. It predominantly affects T-cell receptor (TCR) alphabeta-lineage precursors, with a consequent proportional increase in multipotent thymic precursors. We show that T-acute lymphoblastic leukemias (T-ALLs) demonstrate a similar shift with age from predominantly TCR expressing to an immature (IM0/delta/gamma) stage of maturation arrest. Half demonstrate HOX11, HOX11L2, SIL-TAL1, or CALM-AF10 deregulation, with each being associated with a specific, age-independent stage of maturation arrest. HOX11 and SIL-TAL represent alphabeta-lineage oncogenes, whereas HOX11L2 expression identifies an intermediate alphabeta/gammadelta-lineage stage of maturation arrest. In keeping with preferential alphabeta-lineage involution, the incidence of SIL-TAL1 and HOX11L2 deregulation decreased with age. In contrast, HOX11 deregulation became more frequent, suggesting longer latency. TAL1/LMO1 deregulation is more frequent in alphabeta-lineage T-ALL, when it is predominantly due to SIL-TAL1 rearrangements in children but to currently unknown mechanisms in adolescents and adults. LMO2 was more frequently coexpressed with LYL1, predominantly in IM0/delta/gamma adult cases, than with TAL1. These age-related changes in phenotype and oncogenic pathways probably reflect progressive changes in the thymic population at risk of malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15054041     DOI: 10.1182/blood-2003-11-3944

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.

Authors:  Bronwyn M Owens; Teresa S Hawley; Lisa M Spain; Kristi A Kerkel; Robert G Hawley
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

2.  TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome.

Authors:  P Villarese; C Lours; A Trinquand; S Le Noir; M Belhocine; L Lhermitte; A Cieslak; M Tesio; A Petit; M LeLorch; S Spicuglia; N Ifrah; H Dombret; A W Langerak; N Boissel; E Macintyre; V Asnafi
Journal:  Leukemia       Date:  2017-06-08       Impact factor: 11.528

Review 3.  Recent developments in the management of T-cell precursor acute lymphoblastic leukemia/lymphoma.

Authors:  Adele K Fielding; Lalita Banerjee; David I Marks
Journal:  Curr Hematol Malig Rep       Date:  2012-06       Impact factor: 3.952

4.  Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia.

Authors:  Laurent Renou; Pierre-Yves Boelle; Caroline Deswarte; Salvatore Spicuglia; Aissa Benyoucef; Julien Calvo; Benjamin Uzan; Mohamed Belhocine; Agata Cieslak; Judith Landman-Parker; Andre Baruchel; Vahid Asnafi; Françoise Pflumio; Paola Ballerini; Irina Naguibneva
Journal:  Blood Adv       Date:  2017-05-04

5.  The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest.

Authors:  Raouf Ben Abdelali; Vahid Asnafi; Arnaud Petit; Jean-Baptiste Micol; Céline Callens; Patrick Villarese; Eric Delabesse; Oumedaly Reman; Stephane Lepretre; Jean-Yves Cahn; Gaelle Guillerm; Céline Berthon; Claude Gardin; Bernadette Corront; Thibaut Leguay; Marie-Christine Béné; Norbert Ifrah; Guy Leverger; Hervé Dombret; Elizabeth Macintyre
Journal:  Haematologica       Date:  2013-07-05       Impact factor: 9.941

6.  The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.

Authors:  Yasodha Natkunam; Shuchun Zhao; David Y Mason; Jun Chen; Behnaz Taidi; Margaret Jones; Anne S Hammer; Stephen Hamilton Dutoit; Izidore S Lossos; Ronald Levy
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

7.  Phosphorylation of HOX11/TLX1 on Threonine-247 during mitosis modulates expression of cyclin B1.

Authors:  Edwin Chen; Xiaoyong Huang; Yanzhen Zheng; You-Jun Li; Alden Chesney; Yaacov Ben-David; Eric Yang; Margaret R Hough
Journal:  Mol Cancer       Date:  2010-09-16       Impact factor: 27.401

8.  The CALM and CALM/AF10 interactor CATS is a marker for proliferation.

Authors:  Leticia Fröhlich Archangelo; Philipp A Greif; Michael Hölzel; Thomas Harasim; Elisabeth Kremmer; Gerhard K H Przemeck; Dirk Eick; Aniruddha Jayant Deshpande; Christian Buske; Martin Hrabé de Angelis; Sara Teresinha Olalla Saad; Stefan K Bohlander
Journal:  Mol Oncol       Date:  2008-09-04       Impact factor: 6.603

9.  A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.

Authors:  Katherine Bessette; Mark L Lang; Roy A Fava; Martin Grundy; Jennifer Heinen; Laurie Horne; Rosanne Spolski; Amin Al-Shami; Herbert C Morse; Warren J Leonard; John A Kelly
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

10.  Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis.

Authors:  Irene Riz; Teresa S Hawley; Helen Johnston; Robert G Hawley
Journal:  Br J Haematol       Date:  2009-01-03       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.